Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- 4-AP
- Unspecified disorder of skin and subcutaneous tissue
- 4-PBA
- Unspecified disorder of skin and subcutaneous tissue
- 5-ASA
- Unspecified disorder of skin and subcutaneous tissue
- 5-aminolevulinic acid
- Skin disorder: 0% - 12%
- Unspecified disorder of skin and subcutaneous tissue
- 5-aza-2'-deoxycytidine
- Unspecified disorder of skin and subcutaneous tissue
- 5-azacytidine
- Unspecified disorder of skin and subcutaneous tissue
- 6-mercaptopurine
- Unspecified disorder of skin and subcutaneous tissue: 2%
- 8-MOP
- A77 1726
- Unspecified disorder of skin and subcutaneous tissue
- ACTH(1-39
- Unspecified disorder of skin and subcutaneous tissue
- AMD3100
- Unspecified disorder of skin and subcutaneous tissue
- APAs
- Unspecified disorder of skin and subcutaneous tissue
- Anidulafungin
- Unspecified disorder of skin and subcutaneous tissue: 22.9% - 25.6%
- Azarga
- Unspecified disorder of skin and subcutaneous tissue
- Bivalirudin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Buscopan
- Unspecified disorder of skin and subcutaneous tissue
- CGP 19835A
- Unspecified disorder of skin and subcutaneous tissue
- Cancidas
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 15% - 42%
- D-penicillamine
- Unspecified disorder of skin and subcutaneous tissue
- DFMO
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- Diane-35
- Unspecified disorder of skin and subcutaneous tissue
- Enfuvirtide
- Unspecified disorder of skin and subcutaneous tissue
- Eptifibatide
- Unspecified disorder of skin and subcutaneous tissue
- Estrofem
- Unspecified disorder of skin and subcutaneous tissue
- FK463
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 14.3% - 79.2%
- FTY720
- Unspecified disorder of skin and subcutaneous tissue
- Forteo
- Unspecified disorder of skin and subcutaneous tissue
- Gd-DTPA
- Unspecified disorder of skin and subcutaneous tissue
- Gd-EOB-DTPA
- Unspecified disorder of skin and subcutaneous tissue
- Glat copolymer
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- Goserelin
- Unspecified disorder of skin and subcutaneous tissue
- Histrelin
- Unspecified disorder of skin and subcutaneous tissue
- ICI 182,780
- Unspecified disorder of skin and subcutaneous tissue
- Implanon
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Insulin
- Unspecified disorder of skin and subcutaneous tissue
- K779
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- LY146032
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, rare, 30% - 34.5%
- Lantus
- Unspecified disorder of skin and subcutaneous tissue
- Leuprorelin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Lisinopril
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Lu AA21004
- Unspecified disorder of skin and subcutaneous tissue
- Lyxumia
- Unspecified disorder of skin and subcutaneous tissue
- MDV3100
- Unspecified disorder of skin and subcutaneous tissue
- Metrodin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
- N-acetylcysteine
- Unspecified disorder of skin and subcutaneous tissue
- N-carbamylglutamate
- Unspecified disorder of skin and subcutaneous tissue
- NTBC
- Unspecified disorder of skin and subcutaneous tissue
- NovoLog
- Skin disorder: 2% - 5%
- Unspecified disorder of skin and subcutaneous tissue
- NuvaRing
- Unspecified disorder of skin and subcutaneous tissue
- Nuvocid
- Unspecified disorder of skin and subcutaneous tissue
- Octreotide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Skin disorder
- Oestrogen
- Unspecified disorder of skin and subcutaneous tissue
- Optison
- Unspecified disorder of skin and subcutaneous tissue
- PCI-32765
- Unspecified disorder of skin and subcutaneous tissue
- PGE1
- Photofrin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: 1.45% - 52.5%
- Photofrin II
- Unspecified disorder of skin and subcutaneous tissue
- Promacta
- Unspecified disorder of skin and subcutaneous tissue
- Refludan
- Unspecified disorder of skin and subcutaneous tissue
- Revasc
- Unspecified disorder of skin and subcutaneous tissue
- SU5416
- Unspecified disorder of skin and subcutaneous tissue
- Saxagliptin
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue
- SonoVue
- Unspecified disorder of skin and subcutaneous tissue
- Supremon
- Skin disorder: 1.79%
- Unspecified disorder of skin and subcutaneous tissue
- TMC435
- Unspecified disorder of skin and subcutaneous tissue
- TPGS
- Unspecified disorder of skin and subcutaneous tissue
- TR-700
- Unspecified disorder of skin and subcutaneous tissue
- Terlipressin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Triphasil
- Unspecified disorder of skin and subcutaneous tissue
- Triptorelin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- Trisequens
- Unspecified disorder of skin and subcutaneous tissue
- UDCA
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- VACV
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Vancocine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- abacavir
- Unspecified disorder of skin and subcutaneous tissue
- abacavir-lamivudine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- abiraterone
- Unspecified disorder of skin and subcutaneous tissue
- acamprosate
- Unspecified disorder of skin and subcutaneous tissue: common
- acebutolol
- Unspecified disorder of skin and subcutaneous tissue: 1%
- acetaminophen
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- acitretin
- Skin disorder: postmarketing
- acyclovir
- Unspecified disorder of skin and subcutaneous tissue
- adefovir dipivoxil
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- afatinib
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- agomelatine
- Unspecified disorder of skin and subcutaneous tissue
- albendazole
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- alfentanil
- Unspecified disorder of skin and subcutaneous tissue
- alfuzosin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- aliskiren
- Unspecified disorder of skin and subcutaneous tissue
- allopurinol
- Unspecified disorder of skin and subcutaneous tissue
- almotriptan
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- alosetron
- alprazolam
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, infrequent, 1.1%
- amantadine
- Unspecified disorder of skin and subcutaneous tissue
- amiodarone
- amisulpride
- Skin disorder: 0% - 1%
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- amlodipine
- Unspecified disorder of skin and subcutaneous tissue
- amlodipine besylate
- Unspecified disorder of skin and subcutaneous tissue
- amoxicillin
- Unspecified disorder of skin and subcutaneous tissue
- amphetamine
- Unspecified disorder of skin and subcutaneous tissue
- amphotericin B
- amprenavir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- amsacrine
- Unspecified disorder of skin and subcutaneous tissue
- anagrelide
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- apixaban
- Unspecified disorder of skin and subcutaneous tissue
- apraclonidine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- apremilast
- Unspecified disorder of skin and subcutaneous tissue
- aprepitant
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- aripiprazole
- Unspecified disorder of skin and subcutaneous tissue
- arsenic trioxide
- Unspecified disorder of skin and subcutaneous tissue
- articaine
- atazanavir
- Unspecified disorder of skin and subcutaneous tissue
- atomoxetine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- atorvastatin
- Unspecified disorder of skin and subcutaneous tissue
- atosiban
- Unspecified disorder of skin and subcutaneous tissue
- atovaquone
- Unspecified disorder of skin and subcutaneous tissue
- atracurium
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- avanafil
- Unspecified disorder of skin and subcutaneous tissue
- axitinib
- Unspecified disorder of skin and subcutaneous tissue
- azathioprine
- Unspecified disorder of skin and subcutaneous tissue
- azilsartan medoxomil
- Unspecified disorder of skin and subcutaneous tissue
- baclofen
- Unspecified disorder of skin and subcutaneous tissue
- bazedoxifene
- Unspecified disorder of skin and subcutaneous tissue
- bendamustine
- Unspecified disorder of skin and subcutaneous tissue
- benzoyl
- Unspecified disorder of skin and subcutaneous tissue
- betahistine
- Unspecified disorder of skin and subcutaneous tissue
- betaine
- Unspecified disorder of skin and subcutaneous tissue
- betamethasone valerate
- Unspecified disorder of skin and subcutaneous tissue
- betaxolol
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- bexarotene
- Skin disorder: common, 18% - 26%
- Unspecified disorder of skin and subcutaneous tissue
- bicalutamide
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- bile salt
- Unspecified disorder of skin and subcutaneous tissue
- bimatoprost
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- bisoprolol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- boceprevir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- bortezomib
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- bosentan
- Unspecified disorder of skin and subcutaneous tissue
- bosutinib
- Unspecified disorder of skin and subcutaneous tissue
- brimonidine
- Unspecified disorder of skin and subcutaneous tissue
- brinzolamide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- bromazepam
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- bromhexine
- Unspecified disorder of skin and subcutaneous tissue
- bromocriptine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- budesonide
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- bupivacaine
- Unspecified disorder of skin and subcutaneous tissue: 0% - 8.25%
- buprenorphine
- Unspecified disorder of skin and subcutaneous tissue
- bupropion
- Skin disorder: 1.9% - 2.4%
- Unspecified disorder of skin and subcutaneous tissue: 3%
- busulfan
- Unspecified disorder of skin and subcutaneous tissue
- cabazitaxel
- Unspecified disorder of skin and subcutaneous tissue
- cabozantinib
- Unspecified disorder of skin and subcutaneous tissue
- caffeine
- canagliflozin
- Unspecified disorder of skin and subcutaneous tissue
- candesartan cilexetil
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- capecitabine
- Unspecified disorder of skin and subcutaneous tissue
- capsaicin
- Unspecified disorder of skin and subcutaneous tissue
- carbamazepine
- Unspecified disorder of skin and subcutaneous tissue
- carbimazole
- Unspecified disorder of skin and subcutaneous tissue
- carboplatin
- Unspecified disorder of skin and subcutaneous tissue
- carvedilol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ceftaroline
- Unspecified disorder of skin and subcutaneous tissue
- ceftazidime
- Unspecified disorder of skin and subcutaneous tissue
- ceftobiprole
- Unspecified disorder of skin and subcutaneous tissue
- cefuroxime
- Unspecified disorder of skin and subcutaneous tissue
- celecoxib
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- celiprolol
- cephalexin
- Unspecified disorder of skin and subcutaneous tissue
- cetirizine
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- cevimeline
- chloramphenicol
- Unspecified disorder of skin and subcutaneous tissue
- ciclopirox
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- cidofovir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Skin disorder
- cilazapril
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- cilostazol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- cinacalcet
- Unspecified disorder of skin and subcutaneous tissue
- ciprofloxacin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- cisplatin
- Unspecified disorder of skin and subcutaneous tissue
- citalopram
- Skin disorder: uncommon
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- cladribine
- Unspecified disorder of skin and subcutaneous tissue
- clarithromycin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 3.18% - 3.2%
- clobazam
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- clobetasol
- Unspecified disorder of skin and subcutaneous tissue: 1.67% - 3.33%
- clobetasol propionate
- Unspecified disorder of skin and subcutaneous tissue
- clobetasone butyrate
- Unspecified disorder of skin and subcutaneous tissue
- clodronate
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- clofarabine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- clomipramine
- Unspecified disorder of skin and subcutaneous tissue
- clonazepam
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- clonidine
- Unspecified disorder of skin and subcutaneous tissue
- clopidogrel
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- clozapine
- Unspecified disorder of skin and subcutaneous tissue
- cobicistat
- Unspecified disorder of skin and subcutaneous tissue
- colchicine
- colestimide
- Unspecified disorder of skin and subcutaneous tissue
- conivaptan
- Unspecified disorder of skin and subcutaneous tissue
- copolymer 1
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- cortisol
- Unspecified disorder of skin and subcutaneous tissue
- cosyntropin
- Unspecified disorder of skin and subcutaneous tissue
- crizotinib
- Unspecified disorder of skin and subcutaneous tissue: 0% - 8.72%
- cyclizine
- cyproterone acetate
- Unspecified disorder of skin and subcutaneous tissue
- cysteamine
- Unspecified disorder of skin and subcutaneous tissue
- cytarabine
- Unspecified disorder of skin and subcutaneous tissue
- d-telaprevir
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- dabigatran etexilate
- Unspecified disorder of skin and subcutaneous tissue
- dabrafenib
- Unspecified disorder of skin and subcutaneous tissue
- dalbavancin
- Unspecified disorder of skin and subcutaneous tissue
- dalteparin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: uncommon
- dapagliflozin
- Unspecified disorder of skin and subcutaneous tissue
- darifenacin
- Unspecified disorder of skin and subcutaneous tissue
- darunavir
- Unspecified disorder of skin and subcutaneous tissue
- dasatinib
- Unspecified disorder of skin and subcutaneous tissue
- deferasirox
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- deferiprone
- Unspecified disorder of skin and subcutaneous tissue
- deferoxamine
- Unspecified disorder of skin and subcutaneous tissue
- degarelix
- Unspecified disorder of skin and subcutaneous tissue
- delamanid
- Unspecified disorder of skin and subcutaneous tissue
- delavirdine
- delta 9-THC
- Unspecified disorder of skin and subcutaneous tissue
- demethyl
- Unspecified disorder of skin and subcutaneous tissue
- deprenyl
- Skin disorder: 6%
- Unspecified disorder of skin and subcutaneous tissue
- desmopressin
- Unspecified disorder of skin and subcutaneous tissue
- desogestrel
- Unspecified disorder of skin and subcutaneous tissue
- desonide
- Unspecified disorder of skin and subcutaneous tissue: 2.58% - 3.09%
- desvenlafaxine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- dexrazoxane
- Unspecified disorder of skin and subcutaneous tissue
- diazepam
- Unspecified disorder of skin and subcutaneous tissue
- diclofenac
- Unspecified disorder of skin and subcutaneous tissue
- dihydrocodeine
- Unspecified disorder of skin and subcutaneous tissue
- dipyridamole
- Unspecified disorder of skin and subcutaneous tissue
- disopyramide
- docetaxel
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- dolutegravir
- Unspecified disorder of skin and subcutaneous tissue
- doripenem
- Unspecified disorder of skin and subcutaneous tissue
- doxazosin
- Skin disorder: postmarketing
- doxepin
- Unspecified disorder of skin and subcutaneous tissue
- doxorubicin
- Skin disorder: common
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- dronedarone
- Unspecified disorder of skin and subcutaneous tissue
- drospirenone (DRSP
- Unspecified disorder of skin and subcutaneous tissue
- duloxetine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 6%
- efavirenz
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- eletriptan
- Skin disorder: infrequent
- Unspecified disorder of skin and subcutaneous tissue
- elvitegravir
- Unspecified disorder of skin and subcutaneous tissue
- emedastine
- Unspecified disorder of skin and subcutaneous tissue
- emtricitabine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- entacapone
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- entecavir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- epinephrine
- Unspecified disorder of skin and subcutaneous tissue
- eplerenone
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- eribulin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- erlotinib
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ertapenem
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- eslicarbazepine
- Unspecified disorder of skin and subcutaneous tissue: 1%
- eslicarbazepine acetate
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- esmolol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- estradiol
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- ethosuximide
- Unspecified disorder of skin and subcutaneous tissue
- etoposide
- Unspecified disorder of skin and subcutaneous tissue
- etoricoxib
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- etravirine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- everolimus
- Unspecified disorder of skin and subcutaneous tissue
- exemestane
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- exenatide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ezetimibe
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- famciclovir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- febuxostat
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- fenofibrate
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- fentanyl
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 1% - 13%
- fesoterodine
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- fidaxomicin
- Unspecified disorder of skin and subcutaneous tissue
- flavoxate
- flecainide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- florbetapir
- Unspecified disorder of skin and subcutaneous tissue
- flucloxacillin
- Unspecified disorder of skin and subcutaneous tissue
- fluconazole
- Skin disorder: postmarketing, rare
- Unspecified disorder of skin and subcutaneous tissue
- fludarabine
- fluocinonide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- fluorescein
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- fluoxetine
- Unspecified disorder of skin and subcutaneous tissue
- fluphenazine
- fluphenazine decanoate
- flutamide
- Unspecified disorder of skin and subcutaneous tissue
- fluticasone propionate
- Unspecified disorder of skin and subcutaneous tissue
- fluticasone/salmeterol
- Unspecified disorder of skin and subcutaneous tissue
- fluvastatin
- Unspecified disorder of skin and subcutaneous tissue
- fondaparinux
- Unspecified disorder of skin and subcutaneous tissue
- formoterol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- fosamprenavir
- Unspecified disorder of skin and subcutaneous tissue: rare, common
- fosaprepitant
- Unspecified disorder of skin and subcutaneous tissue
- fosaprepitant dimeglumine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- fosfomycin
- fosfomycin trometamol
- fospropofol
- Unspecified disorder of skin and subcutaneous tissue: 16.1% - 27.6%
- fotemustine
- Unspecified disorder of skin and subcutaneous tissue
- furosemide
- Unspecified disorder of skin and subcutaneous tissue
- fusidic acid
- Unspecified disorder of skin and subcutaneous tissue
- gabapentin
- Skin disorder: infrequent
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- gadobenate dimeglumine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- gadofosveset
- Unspecified disorder of skin and subcutaneous tissue
- gadolinium
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- gadoversetamide
- Unspecified disorder of skin and subcutaneous tissue
- galantamine
- Unspecified disorder of skin and subcutaneous tissue
- ganciclovir
- Unspecified disorder of skin and subcutaneous tissue
- gefitinib
- Unspecified disorder of skin and subcutaneous tissue: very common, 4.6%
- gemcitabine
- Unspecified disorder of skin and subcutaneous tissue
- gemfibrozil
- Unspecified disorder of skin and subcutaneous tissue
- gemifloxacin
- Unspecified disorder of skin and subcutaneous tissue
- gliclazide
- Skin disorder: 1.9% - 2%
- Unspecified disorder of skin and subcutaneous tissue
- glycopyrrolate
- Unspecified disorder of skin and subcutaneous tissue
- granisetron
- Unspecified disorder of skin and subcutaneous tissue
- haloperidol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- hepatitis B vaccines
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- hetastarch
- Unspecified disorder of skin and subcutaneous tissue
- histamine
- Unspecified disorder of skin and subcutaneous tissue
- hydrocodone
- Unspecified disorder of skin and subcutaneous tissue
- hydromorphone
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- hydroxocobalamin
- Unspecified disorder of skin and subcutaneous tissue
- hydroxybutyrate
- Unspecified disorder of skin and subcutaneous tissue
- hydroxychloroquine
- Unspecified disorder of skin and subcutaneous tissue
- hydroxyurea
- Unspecified disorder of skin and subcutaneous tissue
- ibandronate
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: 1.3% - 3%
- ibuprofen
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- icodextrin
- idarubicin
- Unspecified disorder of skin and subcutaneous tissue
- ifosfamide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- iloprost
- Unspecified disorder of skin and subcutaneous tissue
- imatinib
- Skin disorder: 0% - 4.35%
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- imipramine
- Unspecified disorder of skin and subcutaneous tissue
- imiquimod
- Skin disorder
- Skin breakdown: 0.5%
- Unspecified disorder of skin and subcutaneous tissue
- indacaterol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- indapamide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- indinavir
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- insulin detemir
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- iodide
- Unspecified disorder of skin and subcutaneous tissue
- iohexol
- iopromide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ipratropium bromide
- Unspecified disorder of skin and subcutaneous tissue
- irbesartan
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- iron sucrose
- Unspecified disorder of skin and subcutaneous tissue
- isosorbide-5-mononitrate
- isradipine
- Unspecified disorder of skin and subcutaneous tissue
- itraconazole
- Skin disorder: 1% - 2%
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ivabradine
- Unspecified disorder of skin and subcutaneous tissue
- ivacaftor
- Unspecified disorder of skin and subcutaneous tissue
- ixabepilone
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- ketoconazole
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ketorolac tromethamine
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- lacosamide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- lactate
- lamivudine
- Unspecified disorder of skin and subcutaneous tissue
- lanreotide
- Unspecified disorder of skin and subcutaneous tissue
- lansoprazole
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- lapatinib
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- lasofoxifene
- Unspecified disorder of skin and subcutaneous tissue
- latanoprost
- Unspecified disorder of skin and subcutaneous tissue
- leflunomide
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: very rare
- lenalidomide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- lercanidipine
- Unspecified disorder of skin and subcutaneous tissue
- letrozole
- Skin disorder: 0.663% - 32.4%
- Unspecified disorder of skin and subcutaneous tissue
- leucovorin
- leuprorelin acetate
- Unspecified disorder of skin and subcutaneous tissue: uncommon
- levetiracetam
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- levonorgestrel
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- linaclotide
- Unspecified disorder of skin and subcutaneous tissue
- linagliptin
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- linezolid
- Skin disorder: postmarketing, 0% - 2%
- lisdexamfetamine dimesylate
- Unspecified disorder of skin and subcutaneous tissue: 3%
- lithium carbonate
- lomefloxacin
- lomitapide
- Unspecified disorder of skin and subcutaneous tissue
- loperamide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- loratadine
- Unspecified disorder of skin and subcutaneous tissue
- lorcaserin
- Unspecified disorder of skin and subcutaneous tissue
- lormetazepam
- Unspecified disorder of skin and subcutaneous tissue
- lubiprostone
- Unspecified disorder of skin and subcutaneous tissue
- lurasidone
- Unspecified disorder of skin and subcutaneous tissue
- mTHPC
- Unspecified disorder of skin and subcutaneous tissue
- mannitol
- Unspecified disorder of skin and subcutaneous tissue
- maprotiline
- Unspecified disorder of skin and subcutaneous tissue
- maraviroc
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- medroxyprogesterone
- Skin disorder: postmarketing
- medroxyprogesterone acetate
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- mefenamic acid
- Unspecified disorder of skin and subcutaneous tissue
- mefloquine
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- megestrol
- melatonin
- Unspecified disorder of skin and subcutaneous tissue
- meloxicam
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 0% - 4.5%
- melphalan
- Unspecified disorder of skin and subcutaneous tissue: rare
- memantine
- Skin disorder: postmarketing
- meropenem
- Unspecified disorder of skin and subcutaneous tissue: common
- metformin
- Unspecified disorder of skin and subcutaneous tissue
- methotrexate
- Unspecified disorder of skin and subcutaneous tissue
- methyldopa
- Unspecified disorder of skin and subcutaneous tissue
- methylene blue
- Unspecified disorder of skin and subcutaneous tissue
- methylnaltrexone
- Unspecified disorder of skin and subcutaneous tissue
- methylphenidate
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 1.7%
- methylprednisolone
- Unspecified disorder of skin and subcutaneous tissue
- metoprolol
- Unspecified disorder of skin and subcutaneous tissue
- metronidazole
- Unspecified disorder of skin and subcutaneous tissue: 6.35% - 6.46%
- metyrapone
- Unspecified disorder of skin and subcutaneous tissue
- mianserin
- Unspecified disorder of skin and subcutaneous tissue
- midazolam
- Unspecified disorder of skin and subcutaneous tissue
- midodrine
- Unspecified disorder of skin and subcutaneous tissue
- mifepristone
- Unspecified disorder of skin and subcutaneous tissue
- milnacipran
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue
- minoxidil
- Unspecified disorder of skin and subcutaneous tissue
- mirabegron
- Unspecified disorder of skin and subcutaneous tissue
- mirtazapine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- mitotane
- Unspecified disorder of skin and subcutaneous tissue
- mitoxantrone
- mivacurium
- Unspecified disorder of skin and subcutaneous tissue
- modafinil
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- monomethylfumarate
- Unspecified disorder of skin and subcutaneous tissue
- montelukast
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- morphine
- Unspecified disorder of skin and subcutaneous tissue
- moxifloxacin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- mupirocin
- Unspecified disorder of skin and subcutaneous tissue
- mycophenolate mofetil
- Skin disorder: 8.7% - 12.5%
- Unspecified disorder of skin and subcutaneous tissue
- mycophenolic acid
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- nalmefene
- Unspecified disorder of skin and subcutaneous tissue
- naloxone
- Unspecified disorder of skin and subcutaneous tissue
- naltrexone
- Unspecified disorder of skin and subcutaneous tissue
- naproxen
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- naratriptan
- nebivolol
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue
- nelfinavir
- Unspecified disorder of skin and subcutaneous tissue
- neostigmine
- Unspecified disorder of skin and subcutaneous tissue
- nepafenac
- Unspecified disorder of skin and subcutaneous tissue
- nevirapine
- Unspecified disorder of skin and subcutaneous tissue
- niacin
- Unspecified disorder of skin and subcutaneous tissue
- nicorandil
- Unspecified disorder of skin and subcutaneous tissue: very rare
- nifedipine
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- nilotinib
- Unspecified disorder of skin and subcutaneous tissue: 0% - 36%
- nitrogen mustard
- Unspecified disorder of skin and subcutaneous tissue
- nitroglycerin
- Unspecified disorder of skin and subcutaneous tissue
- norethisterone
- Unspecified disorder of skin and subcutaneous tissue
- ofatumumab
- Unspecified disorder of skin and subcutaneous tissue
- ofloxacin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- olanzapine
- Unspecified disorder of skin and subcutaneous tissue
- olmesartan
- Unspecified disorder of skin and subcutaneous tissue
- olodaterol
- Unspecified disorder of skin and subcutaneous tissue
- olopatadine
- Unspecified disorder of skin and subcutaneous tissue
- olsalazine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- omeprazole
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ondansetron
- Unspecified disorder of skin and subcutaneous tissue
- orlistat
- Unspecified disorder of skin and subcutaneous tissue
- orphenadrine
- oseltamivir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ospemifene
- Unspecified disorder of skin and subcutaneous tissue: 1.6%
- oxaliplatin
- Skin disorder: 0.6% - 36%
- Unspecified disorder of skin and subcutaneous tissue
- oxcarbazepine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- oxybutynin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- oxycodone
- Unspecified disorder of skin and subcutaneous tissue
- oxymorphone
- Unspecified disorder of skin and subcutaneous tissue
- oxytocin injection
- Unspecified disorder of skin and subcutaneous tissue
- paclitaxel
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 0% - 5.22%
- paliperidone
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- palonosetron
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- pantoprazole
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- parecoxib
- Unspecified disorder of skin and subcutaneous tissue
- paricalcitol
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- paroxetine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- pazopanib
- Skin disorder: 0% - 11%
- Unspecified disorder of skin and subcutaneous tissue
- pegaptanib
- Unspecified disorder of skin and subcutaneous tissue
- pemetrexed
- Unspecified disorder of skin and subcutaneous tissue
- penciclovir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- pentostatin
- pentoxifylline
- Unspecified disorder of skin and subcutaneous tissue
- perindopril
- Unspecified disorder of skin and subcutaneous tissue
- phenylephrine
- Unspecified disorder of skin and subcutaneous tissue
- phenyllactate
- pimecrolimus
- Unspecified disorder of skin and subcutaneous tissue
- pimozide
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- pioglitazone
- Unspecified disorder of skin and subcutaneous tissue
- piperacillin
- Unspecified disorder of skin and subcutaneous tissue
- pirfenidone
- Unspecified disorder of skin and subcutaneous tissue
- pixantrone
- Unspecified disorder of skin and subcutaneous tissue
- podophyllotoxin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- pomalidomide
- Unspecified disorder of skin and subcutaneous tissue
- ponatinib
- Unspecified disorder of skin and subcutaneous tissue
- posaconazole
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: 1.72% - 4.17%
- pramipexole
- Skin disorder: 2%
- Unspecified disorder of skin and subcutaneous tissue
- prasugrel
- Unspecified disorder of skin and subcutaneous tissue
- praziquantel
- Unspecified disorder of skin and subcutaneous tissue
- prednisone
- Unspecified disorder of skin and subcutaneous tissue
- pregabalin
- Skin disorder: infrequent
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- primidone
- Unspecified disorder of skin and subcutaneous tissue
- prochlorperazine
- progesterone
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- proguanil
- Unspecified disorder of skin and subcutaneous tissue
- propafenone
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- propranolol
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- prostacyclin
- Unspecified disorder of skin and subcutaneous tissue
- prucalopride
- Unspecified disorder of skin and subcutaneous tissue
- quetiapine
- Unspecified disorder of skin and subcutaneous tissue
- quinapril
- Unspecified disorder of skin and subcutaneous tissue
- quinidine
- Unspecified disorder of skin and subcutaneous tissue
- raloxifene
- Unspecified disorder of skin and subcutaneous tissue
- raltegravir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- ramipril
- Unspecified disorder of skin and subcutaneous tissue
- ranolazine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- rapamycin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: rare
- rasagiline
- Unspecified disorder of skin and subcutaneous tissue
- reboxetine
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: 14.3%
- regadenoson
- Unspecified disorder of skin and subcutaneous tissue
- regorafenib
- Unspecified disorder of skin and subcutaneous tissue
- remifentanil
- Unspecified disorder of skin and subcutaneous tissue
- repaglinide
- Unspecified disorder of skin and subcutaneous tissue
- retapamulin
- Unspecified disorder of skin and subcutaneous tissue
- retinoic acid
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- Skin disorder: very common, 0% - 8%
- ribavirin
- Skin disorder: common, 47%
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- rifabutin
- Unspecified disorder of skin and subcutaneous tissue
- rifampicin
- Unspecified disorder of skin and subcutaneous tissue
- rifapentine
- rifaximin
- Unspecified disorder of skin and subcutaneous tissue
- rilpivirine
- Unspecified disorder of skin and subcutaneous tissue
- riluzole
- Skin disorder: infrequent, uncommon
- Unspecified disorder of skin and subcutaneous tissue
- rimonabant
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- risedronate
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- risperidone
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 0% - 52%
- ritonavir
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- rivaroxaban
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- rivastigmine
- Skin disorder: frequent
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- roflumilast
- Unspecified disorder of skin and subcutaneous tissue
- ropinirole
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: 3%
- ropivacaine
- rotigotine
- Unspecified disorder of skin and subcutaneous tissue
- rufinamide
- Unspecified disorder of skin and subcutaneous tissue
- ruxolitinib
- Unspecified disorder of skin and subcutaneous tissue
- salbutamol
- Skin disorder: postmarketing
- salmon calcitonin acetate
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- saquinavir
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- scopolamine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- sertraline
- Skin disorder: postmarketing, rare
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- sevelamer hydrochloride
- sevoflurane
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- sibutramine
- sildenafil
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- silodosin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- sitagliptin
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- sitaxsentan
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- sofosbuvir
- Unspecified disorder of skin and subcutaneous tissue
- solifenacin
- Unspecified disorder of skin and subcutaneous tissue
- sorafenib
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- stavudine
- Unspecified disorder of skin and subcutaneous tissue: very rare
- stiripentol
- Unspecified disorder of skin and subcutaneous tissue
- strontium ranelate
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- sulfasalazine
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- sumatriptan
- sunitinib
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- tacrolimus
- Skin disorder: 1% - 4%
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
- tadalafil
- Unspecified disorder of skin and subcutaneous tissue
- tamsulosin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- tapentadol
- Unspecified disorder of skin and subcutaneous tissue
- teduglutide
- Unspecified disorder of skin and subcutaneous tissue
- tegaserod
- Unspecified disorder of skin and subcutaneous tissue
- telavancin
- Unspecified disorder of skin and subcutaneous tissue
- telithromycin
- Unspecified disorder of skin and subcutaneous tissue
- telmisartan
- Skin disorder: common
- Unspecified disorder of skin and subcutaneous tissue: rare
- temozolomide
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue
- temsirolimus
- Unspecified disorder of skin and subcutaneous tissue
- tenofovir
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- tenofovir disoproxil fumarate
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, 5%
- tenoxicam
- Unspecified disorder of skin and subcutaneous tissue
- terbinafine
- Skin disorder: 1.9%
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- tesamorelin
- Unspecified disorder of skin and subcutaneous tissue
- testosterone
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- testosterone enanthate
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- testosterone propionate
- Unspecified disorder of skin and subcutaneous tissue
- testosterone undecanoate
- Unspecified disorder of skin and subcutaneous tissue
- tetrabenazine
- Unspecified disorder of skin and subcutaneous tissue
- tetraen
- Unspecified disorder of skin and subcutaneous tissue
- tetrahydrobiopterin
- Unspecified disorder of skin and subcutaneous tissue: 5.41%
- thalidomide
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- thiotepa
- Unspecified disorder of skin and subcutaneous tissue
- thymidine
- Unspecified disorder of skin and subcutaneous tissue
- tibolone
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- ticagrelor
- Unspecified disorder of skin and subcutaneous tissue
- tigecycline
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- timolol
- Unspecified disorder of skin and subcutaneous tissue
- tinidazole
- Unspecified disorder of skin and subcutaneous tissue
- tiotropium
- Unspecified disorder of skin and subcutaneous tissue
- tipranavir
- Unspecified disorder of skin and subcutaneous tissue
- tizanidine
- Unspecified disorder of skin and subcutaneous tissue
- tobramycin
- Unspecified disorder of skin and subcutaneous tissue
- tofacitinib
- Unspecified disorder of skin and subcutaneous tissue
- tolcapone
- Skin disorder: infrequent
- Unspecified disorder of skin and subcutaneous tissue: common
- tolvaptan
- Unspecified disorder of skin and subcutaneous tissue
- topiramate
- Skin disorder: 1% - 3.1%
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- topotecan
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- toremifene
- Unspecified disorder of skin and subcutaneous tissue
- trabectedin
- Unspecified disorder of skin and subcutaneous tissue
- tramadol
- Skin disorder: postmarketing, uncommon
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- tramazoline
- Unspecified disorder of skin and subcutaneous tissue
- trametinib
- Unspecified disorder of skin and subcutaneous tissue
- trandolapril
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- travoprost
- Unspecified disorder of skin and subcutaneous tissue: uncommon
- trifluoperazine
- trimethoprim
- Unspecified disorder of skin and subcutaneous tissue
- trimethoprim-sulfamethoxazole
- Unspecified disorder of skin and subcutaneous tissue
- tropisetron
- Unspecified disorder of skin and subcutaneous tissue
- trospium chloride
- Unspecified disorder of skin and subcutaneous tissue
- trovafloxacin
- ulipristal
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- umeclidinium
- Unspecified disorder of skin and subcutaneous tissue
- ustekinumab
- Unspecified disorder of skin and subcutaneous tissue
- v 1784
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue
- valganciclovir
- Unspecified disorder of skin and subcutaneous tissue
- valproate
- Unspecified disorder of skin and subcutaneous tissue
- valsartan
- Unspecified disorder of skin and subcutaneous tissue
- vandetanib
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- vardenafil
- Unspecified disorder of skin and subcutaneous tissue
- varenicline
- Unspecified disorder of skin and subcutaneous tissue
- vecuronium
- Unspecified disorder of skin and subcutaneous tissue
- vemurafenib
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
- vernakalant
- Unspecified disorder of skin and subcutaneous tissue
- verteporfin
- Unspecified disorder of skin and subcutaneous tissue
- vigabatrin
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue: postmarketing, common
- vilazodone
- Unspecified disorder of skin and subcutaneous tissue
- vildagliptin
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- vinflunine
- Unspecified disorder of skin and subcutaneous tissue
- vinorelbine
- Skin disorder: postmarketing
- Unspecified disorder of skin and subcutaneous tissue
- vismodegib
- Unspecified disorder of skin and subcutaneous tissue
- voriconazole
- Skin disorder
- Unspecified disorder of skin and subcutaneous tissue
- warfarin
- x M22
- Unspecified disorder of skin and subcutaneous tissue
- zalcitabine
- zaleplon
- Unspecified disorder of skin and subcutaneous tissue: uncommon
- zanamivir
- Unspecified disorder of skin and subcutaneous tissue
- ziconotide
- Unspecified disorder of skin and subcutaneous tissue
- zidovudine
- Unspecified disorder of skin and subcutaneous tissue
- ziprasidone
- Unspecified disorder of skin and subcutaneous tissue: postmarketing
- zoledronic acid
- Unspecified disorder of skin and subcutaneous tissue
- zolmitriptan
- Skin disorder: infrequent
- zolpidem
- Unspecified disorder of skin and subcutaneous tissue
- zonisamide
- Unspecified disorder of skin and subcutaneous tissue
- zuclopenthixol
- Unspecified disorder of skin and subcutaneous tissue
|
Drugs with this indication
|
